Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:43 PM
Ignite Modification Date:
2025-12-26 @ 2:43 PM
NCT ID:
NCT05055206
Eligibility Criteria:
Inclusion Criteria:
* Patient has lateralized oropharyngeal carcinoma (tonsil or tongue base) not involving midline
* Has squamous cell carcinoma, T1-3 tumours, with no contralateral nodes on clinical exam or axial imaging
* Human papillomavirus (HPV) positive or negative
* Patient should have normal organ function as per Investigator judgement
* Patient is planned for definitive or adjuvant radiotherapy (RT) or chemo radiotherapy (CRT) with bilateral neck RT, or surgery
* Eastern Cooperative Oncology Group (ECOG) performance status 0-1
Exclusion Criteria:
* T4 tumours
* Contralateral/bilateral nodal disease or node(s) \> 6cm on clinical exam or axial imaging or positron emission tomography (PET)
* Primary tumour involving or crossing midline
* Soft palate or posterior pharyngeal wall tumour subsites
* Previous head and neck cancer
* Previous radiotherapy (RT) to the head and neck
* Previous neck dissection
* Distant metastases
* Prior invasive malignancy (except non-melanoma skin cancer) unless disease free for 3 years
* Prior radiotracer allergy
* Multiple primary head and neck cancers
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05055206
Study Brief:
Protocol Section:
NCT05055206